At the molecular level, investigational strategies such as CRISPR-Cas9 and CRISPR-Cas12 gene-editing systems are intended to remove or induce inactivating mutations inside embedded proviral DNA, as well as alter host entrance co-receptors such as CCR5 to provide cellular resistance to infection. The gene discussed is AQP1; the disease is infection.